During the past decade, Bovenij Ziekenhuis conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bovenij Ziekenhuis" #1 sponsor was "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 2 trials, followed by "Amsterdam UMC, location VUmc" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Borstkanker Onderzoek Groep" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bovenij Ziekenhuis" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Netherlands Heart Foundation" with 2 trials as a collaborator, "ZonMw: The Netherlands Organisation for Health Research and Development" with 2 trials as a collaborator, "AO Research Fund" with 1 trials as a collaborator and "Borstkanker Onderzoek Groep" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Bovenij Ziekenhuis" are "Heart Failure" (3 trials), "Cardiovascular Disease" (2 trials), "Atrial Fibrillation" (1 trials), "Breast Neoplasm Female" (1 trials) and "Cardiovascular Diseases" (1 trials). Many other conditions were trialed in "Bovenij Ziekenhuis" in a lesser frequency.

Most popular intervention types in "Bovenij Ziekenhuis" are "Drug" (12 trials), "Device" (1 trials), "Dietary Supplement" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Empagliflozin" (2 trials), "bococizumab (PF-04950615)" (2 trials), "Abiraterone" (1 trials) and "Amoxicillin-clavulanate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bovenij Ziekenhuis" are 11 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Bovenij Ziekenhuis". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Bovenij Ziekenhuis, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Bovenij Ziekenhuis, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 4 trials that are defined as “Not Applicable".